Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Biowreck
Article By:
Tim Knight
Tuesday, March 23, 2021 1:36 PM EDT
XBI has clearly broken below its ascending trendline, as so many stocks and funds are doing these days.
In this article: XBI
Novavax ETFs To Shine Bright On Positive Vaccine Update
Article By:
Zacks Investment Research
Saturday, March 13, 2021 4:15 PM EDT
Novavax NVAX is a formidable name on the list of companies, which are developing a COVID-19 vaccine. Here are a few ETFs that are exposed to Novavax, which was up around 22% in after-hour trading after the announcement of encouraging vaccine data.
Speculative Appetite Is Sinking In Biotech With Latest Rotation
Article By:
Rod Raynovich
Thursday, March 4, 2021 5:38 AM EDT
As we have noted in recent posts there is less appetite for speculative trades in biotech. Some of it is related to concerns in the general market about rising Ten Year Treasury yields and supported by weak technicals.
Biotech Review - Waiting For A Reset
Good analysis. However, you missed the hourly chart. The biotech correction on the daily is possibly over. Why? Because the daily averages crossed and point upward on hourly chart. Talking daily, the current candle is perfectly sitting on the trend line support and between the 10sma and 30 ema with $XBI on a intact uptrend. So all stars seem aligned for the XBI to resume in a upward channel.
Leadership (Bio-Tech) Breakout; Good Sign For Broad Market
My Simple Forecast:
Looks like $XBI has had a positive growth trend. With middle of the year approaching I believe that the cycle will repeat, thus hitting high points again. The seasonal patterns may be based on the rate of discovery of new technology, so cycles may be of unusual lengths. Nonetheless, looks like $XBI is positively correlated to SP500, and it is leading variable. We can anticipate new highs by beginning Q3.